FIVE PRIME THERAPEUTICS INC filings

SEC filings by FIVE PRIME THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2022-02-15Rock Springs Capital Management LPFIVE PRIME THERAPEUTICS, INC.00.0%EDGAR
SC 13G/A2021-05-17RA CAPITAL MANAGEMENT, L.P.FIVE PRIME THERAPEUTICS, INC.00.0%EDGAR
SC 13D2021-03-15Magnetar Financial LLCFIVE PRIME THERAPEUTICS, INC.2,443,7685.3%EDGAR
SC 13G/A2021-03-08BIOTECHNOLOGY VALUE FUND L PFIVE PRIME THERAPEUTICS, INC.3,372,0987.3%EDGAR
SC 13G2021-03-01Rock Springs Capital Management LPFIVE PRIME THERAPEUTICS, INC.3,041,5596.9%EDGAR
SC 13G2021-02-16RA CAPITAL MANAGEMENT, L.P.FIVE PRIME THERAPEUTICS, INC.4,285,1619.8%EDGAR
SC 13G2021-02-16RTW INVESTMENTS, LPFIVE PRIME THERAPEUTICS, INC.2,515,7885.7%EDGAR
SC 13G2021-02-02BlackRock Inc.FIVE PRIME THERAPEUTICS, INC.2,959,0316.7%EDGAR
SC 13G2021-02-01BIOTECHNOLOGY VALUE FUND L PFIVE PRIME THERAPEUTICS, INC.1,657,2433.8%EDGAR
SC 13G2020-12-08BlackRock Inc.FIVE PRIME THERAPEUTICS, INC.2,125,1774.8%EDGAR
SC 13D/A2020-11-13BIOTECHNOLOGY VALUE FUND L PFIVE PRIME THERAPEUTICS, INC.670,6951.8%EDGAR
SC 13D/A2020-10-08BIOTECHNOLOGY VALUE FUND L PFIVE PRIME THERAPEUTICS, INC.4,336,87511.8%EDGAR
SC 13G/A2020-02-14GREAT POINT PARTNERS LLCFIVE PRIME THERAPEUTICS, INC.00.0%EDGAR
SC 13G/A2020-02-05BlackRock Inc.FIVE PRIME THERAPEUTICS, INC.2,535,8197.0%EDGAR
SC 13D2019-12-27BIOTECHNOLOGY VALUE FUND L PFIVE PRIME THERAPEUTICS, INC.3,929,79210.8%EDGAR
SC 13G/A2019-12-09WELLINGTON MANAGEMENT GROUP LLPFIVE PRIME THERAPEUTICS, INC.1,280,7503.5%EDGAR
SC 13G/A2019-11-12FMR LLCFIVE PRIME THERAPEUTICS, INC.5000.0%EDGAR
SC 13G/A2019-11-08BIOTECHNOLOGY VALUE FUND L PFIVE PRIME THERAPEUTICS, INC.2,958,5038.1%EDGAR
SC 13G/A2019-10-02BIOTECHNOLOGY VALUE FUND L PFIVE PRIME THERAPEUTICS, INC.2,046,3115.6%EDGAR
SC 13G/A2019-07-10FMR LLCFIVE PRIME THERAPEUTICS INC1,808,6845.0%EDGAR